ArticleTranslational lung cancer research2021

First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis.

Francesco Facchinetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.